7 European Projects Found
Searched on 125080 European Projects
FINISHED
European Research Infrastructures for Poverty Related Diseases (EURIPRED)
Start date: Nov 1, 2013, End date: Oct 31, 2017,
HIV/AIDS, Tuberculosis (TB) and Malaria alone account for more than six million deaths worldwide every year. Despite substantial efforts made in recent years, Poverty Related Diseases are still spreading. New therapeutic interventions are therefore urgently required to combat Poverty Related Diseases. The existence of a well-developed HIV/TB/Malaria infrastructure presents a prime opportunity to a ...
Read Project
18
Partners Participants
FINISHED
The impact of DEmographic Changes on Infectious DisEases transmission and control in middle/low income countries (DECIDE)
Start date: Apr 1, 2012, End date: Mar 31, 2017,
Population structure and change and social contact patterns are major determinants of the observed epidemiology of infectious diseases, including the consequences on health. Demographic structure and the components of demographic dynamics are changing over time and substantially differ within countries and most critically between countries. However, some of the overall consequences of demographic ...
Read Project
4
Partners Participants
FINISHED
African Vector Control: New Tools (AvecNet)
Start date: Feb 1, 2011, End date: Dec 31, 2016,
The AvecNet consortium will develop practical solutions to the current limitations of vector control strategies in Africa using a combination of translationally-aware, state of the art science and end user analysis to ensure successful development and uptake of the new and improved approaches to malaria control and elimination. Our carefully balanced, multidisciplinary team of European and Africa ...
Read Project
17
Partners Participants
FINISHED
Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research Initiative (IDEA)
Start date: Mar 1, 2010, End date: Aug 31, 2015,
Worm infections are receiving increased attention due to: the wide geographic overlap in occurrence between worms and HIV, TB and malaria; the large proportion of individuals (minimal estimates around 25%) co-infected with worms and HIV/TB/ malaria; the potential risk of increasing disease burden; the very limited understanding of the impact by worm infections on HIV-, TB- and malaria-specific imm ...
Read Project
23
Partners Participants
FINISHED
Health, environmental change and adaptive capacity: mapping, examining and anticipating future risks of water-related vector-borne diseases in eastern Africa (HEALTHY FUTURES)
Start date: Jan 1, 2011, End date: Dec 31, 2014,
The HEALTHY FUTURES project is motivated by concern for the health impacts of environmental changes. HEATHLY FUTURES aims to respond to this concern through construction of a disease risk mapping system for three water-related high-impact VBDs (malaria, Rift valley fever and schistosomiasis) in Africa, accounting for environmental/climatic trends and changes in socio-economic conditions to predic ...
Read Project
17
Partners Participants
FINISHED
Genome-driven vaccine development for bacterial infections (GENDRIVAX)
Start date: Jan 1, 2011, End date: Dec 31, 2014,
...WTSI), academic institution working in the research areas of genetics.3. Swiss Tropical Institute (STI), a public non-commercial organisation with the mission of contributing to health development.4. Kenya Medical Research Institute (KEMRI), the national body responsible for carrying out health science research in Kenya.The four partners have existing links that form the basis for developing an ef ...
Read Project
4
Partners Participants
FINISHED
The targeted development of a new generation Vaccine for Schistosomiasis (TheSchistoVac)
Start date: Feb 1, 2010, End date: Jul 31, 2014,
The aim of this project is to develop a new generation vaccine for schistosomiasis. The vaccine will be based on exposed proteins and/or glycans of the vulnerable skin stage schistosomula, making it safe and effective. The life stage-specific vaccine target selection strategy is based on state-of-the-art schistosomal transcriptomics and glycomics technologies and data, and unique serum and sample ...
Read Project
